CN107427509B - 含有碱性药物和山梨酸的经皮吸收组成物 - Google Patents

含有碱性药物和山梨酸的经皮吸收组成物 Download PDF

Info

Publication number
CN107427509B
CN107427509B CN201580078659.1A CN201580078659A CN107427509B CN 107427509 B CN107427509 B CN 107427509B CN 201580078659 A CN201580078659 A CN 201580078659A CN 107427509 B CN107427509 B CN 107427509B
Authority
CN
China
Prior art keywords
sorbic acid
basic
percutaneous absorption
component
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580078659.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN107427509A (zh
Inventor
滨本英利
三轮泰司
赤泽直哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virtue Alix Corp
Original Assignee
Virtue Alix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virtue Alix Corp filed Critical Virtue Alix Corp
Publication of CN107427509A publication Critical patent/CN107427509A/zh
Application granted granted Critical
Publication of CN107427509B publication Critical patent/CN107427509B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201580078659.1A 2015-08-29 2015-08-29 含有碱性药物和山梨酸的经皮吸收组成物 Active CN107427509B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2015/074553 WO2017037813A1 (ja) 2015-08-29 2015-08-29 塩基性薬物とソルビン酸とを含有する経皮吸収組成物

Publications (2)

Publication Number Publication Date
CN107427509A CN107427509A (zh) 2017-12-01
CN107427509B true CN107427509B (zh) 2021-06-15

Family

ID=58187853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580078659.1A Active CN107427509B (zh) 2015-08-29 2015-08-29 含有碱性药物和山梨酸的经皮吸收组成物

Country Status (15)

Country Link
EP (1) EP3342423B1 (enExample)
JP (2) JP6259117B2 (enExample)
KR (1) KR20180039622A (enExample)
CN (1) CN107427509B (enExample)
BR (1) BR112018001387B8 (enExample)
CO (1) CO2018001831A2 (enExample)
ES (1) ES2864017T3 (enExample)
MX (1) MX388148B (enExample)
MY (1) MY189987A (enExample)
PH (1) PH12018500271A1 (enExample)
RU (1) RU2702356C2 (enExample)
SG (1) SG11201800043UA (enExample)
UA (1) UA123212C2 (enExample)
WO (2) WO2017037813A1 (enExample)
ZA (1) ZA201800296B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2968551T3 (es) * 2018-01-31 2024-05-10 Medrx Co Ltd Sistema terapéutico de tizanidina
TWI772807B (zh) * 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑
EP4395749B1 (en) * 2021-08-30 2025-11-19 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid
EP4415696A1 (en) * 2021-10-15 2024-08-21 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system for the transdermal administration of tizanidine
CN116370439A (zh) * 2022-04-01 2023-07-04 江苏山信药业有限公司 一种伐尼克兰透皮贴剂及其制备方法和其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1372463A (zh) * 1999-07-27 2002-10-02 久光制药株式会社 外用贴剂
CN101143127A (zh) * 2007-10-25 2008-03-19 复旦大学 一种酚妥拉明外用制剂及其制备方法
WO2011027786A1 (ja) * 2009-09-07 2011-03-10 ニプロパッチ株式会社 経皮吸収型製剤
CN102858321A (zh) * 2010-06-18 2013-01-02 莫茨药物股份两合公司 用于局部使用1-氨基-烷基环己烷衍生物的凝胶制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61172830A (ja) * 1985-01-26 1986-08-04 Showa Denko Kk 皮膚外用剤組成物
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
ES2334681T3 (es) * 2004-03-19 2010-03-15 Mcneil Ab Medios para la administracion transdermica de nicotina.
JP4807974B2 (ja) * 2005-06-30 2011-11-02 帝國製薬株式会社 経皮吸収促進組成物
CN101032474B (zh) * 2006-03-06 2011-02-16 重庆医药工业研究院有限责任公司 一种治疗或预防神经系统疾病的雷沙吉兰透皮贴片及其制备方法
EP3011954A1 (en) * 2007-11-22 2016-04-27 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
JP5537412B2 (ja) * 2008-02-27 2014-07-02 久光製薬株式会社 貼付製剤
JP2012158521A (ja) * 2009-04-17 2012-08-23 Kureha Corp 外用剤
IN2014DN10706A (enExample) * 2012-06-20 2015-09-04 Medrx Co Ltd

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1372463A (zh) * 1999-07-27 2002-10-02 久光制药株式会社 外用贴剂
CN101143127A (zh) * 2007-10-25 2008-03-19 复旦大学 一种酚妥拉明外用制剂及其制备方法
WO2011027786A1 (ja) * 2009-09-07 2011-03-10 ニプロパッチ株式会社 経皮吸収型製剤
CN102858321A (zh) * 2010-06-18 2013-01-02 莫茨药物股份两合公司 用于局部使用1-氨基-烷基环己烷衍生物的凝胶制剂

Also Published As

Publication number Publication date
MX388148B (es) 2025-03-19
BR112018001387B1 (pt) 2023-09-05
JP6259117B2 (ja) 2018-01-10
BR112018001387B8 (pt) 2024-03-05
KR20180039622A (ko) 2018-04-18
JP2017149782A (ja) 2017-08-31
WO2017038767A1 (ja) 2017-03-09
EP3342423A4 (en) 2018-07-25
WO2017037813A1 (ja) 2017-03-09
EP3342423B1 (en) 2021-03-10
CO2018001831A2 (es) 2018-05-21
CN107427509A (zh) 2017-12-01
UA123212C2 (uk) 2021-03-03
BR112018001387A2 (pt) 2018-09-11
JPWO2017038767A1 (ja) 2017-09-07
PH12018500271A1 (en) 2018-08-13
RU2018110617A3 (enExample) 2019-09-30
ZA201800296B (en) 2019-04-24
EP3342423A1 (en) 2018-07-04
RU2018110617A (ru) 2019-09-30
MX2018002015A (es) 2018-06-19
ES2864017T3 (es) 2021-10-13
RU2702356C2 (ru) 2019-10-08
SG11201800043UA (en) 2018-02-27
MY189987A (en) 2022-03-22

Similar Documents

Publication Publication Date Title
US11382978B2 (en) Percutaneous absorption composition
CN107427509B (zh) 含有碱性药物和山梨酸的经皮吸收组成物
JP5698837B2 (ja) 貼付剤の製造方法及び貼付剤
JP5392495B2 (ja) リドカインテープ剤
US9370495B2 (en) Adhesive patch
ES2805342T3 (es) Parche cutáneo adhesivo
JP6161142B1 (ja) 酸捕捉剤を含有する貼付製剤
WO2014051128A1 (ja) 貼付剤
CN104114167A (zh) 贴剂
JP5615899B2 (ja) 経皮吸収製剤
TW201538179A (zh) 貼附製劑
CN105722502A (zh) 经皮吸收胶体型液体制剂
JP6729584B2 (ja) 経皮吸収型貼付剤
US20170056503A1 (en) Patch preparation containing an acid scavenger

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: Xishan 431-7, dongxiangchuan City, Xiangchuan County, Japan

Applicant after: MEDRX Co.,Ltd.

Address before: Xishan 431-7, dongxiangchuan City, Xiangchuan County, Japan

Applicant before: MEDRX Co.,Ltd.

GR01 Patent grant
GR01 Patent grant